Oligonucleotide CDMO Market worth $11.14 billion by 2031 - Exclusive Report by MarketsandMarkets™

Neutral

AI Analysis

Summary

MarketsandMarkets projects the Oligonucleotide CDMO market to grow from $3.88 billion in 2026 to $11.14 billion by 2031 at a 23.5% CAGR. This is a market research report with no material company-specific news.

Financial Highlights

Guidance

Oligonucleotide CDMO Market projected to reach USD 11.14 billion by 2031 from USD 3.88 billion in 2026, at a CAGR of 23.5%

Importance:2/10

Sentiment:

0.00

market analysisCDMOoligonucleotidemarket projection

Read the original article

Published by PR Newswire Biotech on August 31, 2026 2:15 PM

Read Original